Broad Antibacterial Spectrum Drus Sitafloxacin CAS 127254-10-8

Unit Price: USD 1.0000 / Gram
Payment Type: T/T
Incoterm: CIF
Min. Order: 1 Gram
Delivery Time: 15 Days

Basic Info

Model No.: 127254-10-8

Additional Info

Packaging: As Quantity

Productivity: As Order


Transportation: Air

Place of Origin: CHINA

Supply Ability: IN STOCK

Product Description

Sitafloxacin CAS number is 127254-10-8, It is a fourth-generation fluoroquinolones,it first marketed in Japan in 2008 for the treatment of severe refractory infectious diseases, there are two dosage forms in 50mg tablets and 10% fine-particle. It can inhibit the bacterial DNA gyrase and topoisomerase IV, and the inhibition of the two enzymes is stronger than that of other quinolones.Sitafloxacin CAS 127254-10-8 has a broad antibacterial spectrum. It not only has antibacterial activity against gram-negative bacteria, but also has strong antibacterial activity against gram-positive bacteria, anaerobes, mycoplasma, chlamydia, etc., and is also common to many clinically-resistant fluoroquinolones. It has good bactericidal effect; showed good medical effect in clinical trials: sitafloxacin for pharyngitis, tonsillitis, acute bronchitis, pneumonia, chronic respiratory secondary infection, cystitis, pyelonephritis, urethritis, Cervicitis, otitis media, sinusitis, periodontal inflammation, pericoronitis, jaw bone inflammation have a good effect.
Sitaxacin has selective toxic effects on bacteria, and has broad antibacterial spectrum, strong antibacterial activity, simple structure, convenient administration, and no cross-resistance with other common antibiotics. IT has the advantages of low industrial production difficulty and ideal curative effect. Compared to similar and cephalosporin antibiotics, sitafloxacin has superior antibacterial activity in vitro than existing quinolone antibiotics; it also has anti-intestinal activity twice that of ciprofloxacin and other antibacterial agents Pathobacterial activity, and its activity is not affected by different media, pH, inoculum or human serum.
Due to the presence of a cis-fluorocyclopropylamine group in the structure of sitafloxacin, it has good pharmacokinetic properties and can reduce adverse reactions. It can be developed for oral administration as well as for injection. It has good oral absorption, bioavailability of more than 70%, tissue distribution is wide, drug concentrations in various tissues outside the central nervous system are higher than the concentration of serum drugs, therefore, sitafloxacin is expected to become the treatment of respiratory tract, urogenital tract, An important drug for single or mixed bacterial infections such as peritoneal cavity and skin soft tissue.

Thera. Category: antibiotic

Cas No.:127254-10-8

Synonyms: SitafloxacinisomerⅢ(RRS);sitafloxacin isomer III(RRS);3-Quinolinecarboxylic acid, 7-[(7R)-7-aMino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-1,4-dihydro-4-oxo-;7-((R)-7-Amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4;7-[(7R)-7-amino-5-azaspiro[2.4]hept-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluoro-cyclopropyl]-1,4-dihydro-4-oxo-Quinolin-3-carboxylic acid;Sitafloxacin Isomer Impurity 7;7-[(4S)-4-Amino-6-azaspiro[2.4]heptan-6-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid;Sitafloxacin;




Assay: ≥99%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Usage: Use to making Sitafloxacin which is a fluoroquinolone antibiotic that shows promise in the treatment of Buruli ulcer. 

Active Pharmaceutical Ingredients> Cas 90098-04-7,Rebamipide Named In Mucosta With GMP Standard
Active Pharmaceutical Ingredients> Functional Dyspepsia Treatment Acotiamide Hydrochloride Trihydrate CAS 773092-05-0
Active Pharmaceutical Ingredients> Acotiamide Hydrochloride For Gastric Motility Improvement CAS 185104-11-4
Contract Manufacturing> ASCORBYL GLUCOSIDE Used for Comesitc Additive CAS 129499-78-1
Pharmaceutical Intermediates> Anti-Ulcerative> 2-Aminothiazole-4-ethylformate For Making Acotiamide Cas 5398-36-7
Pharmaceutical Intermediates> Anti-Ulcerative> Acotiamide INT CAS NUMBER 185105-98-0
Pharmaceutical Intermediates> Anti-Cardiovascular> Azilsartan Used for Hypertension Treatment CAS 147403-03-0
Pharmaceutical Intermediates> Anti-Diabetes> Sitagliptin Phosphate Monohydrate Treated for Type 2 diabetes CAS Number 654671-77-9
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 132210-24-3, 2-Amino-3-(1,2-dihydro-2-oxo-quinoline-4-yl)Propanoic acid Hydrochloride For Rebamipide
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 1068-90-2 White Crystalline Powder Diethyl Acetamidomalonate For Rebamipide(DAAM)
Active Pharmaceutical Ingredients> 6027-23-2, Hordenine HCL Powder
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 4876-10-2,4-Bromomethyl-2(1H)-quinolinone (BMQ) For Rebamipide/ Mucosta
Pharmaceutical Intermediates> Anti-Respiratory> CAS 2338-18-3, 2-Aminoindan hydrochloride For Making Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> CAS 312753-53-0/ 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride Used for Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> 312753-53-0, Indacaterol Intermediate
Pharmaceutical Intermediates> Anti-Respiratory> 100331-89-3, Indacaterol Intermediate

© 2019 CHINA WAY. All Rights Reserved.  Taizhou Volsen Chemical Co., Ltd.,  Inc.   All rights reserved. site map.  sitemap.html